Filter
1033
Filtered Results: 1033
Text search:
síndrome
de
Down
Featured
Recommendations
127
New Publications
245
Language
Document type
No document type
632
Guidelines
168
Studies & Reports
123
Manuals
60
Strategic & Response Plan
20
Training Material
14
Fact sheets
10
Situation Updates
4
Infographics
2
Countries / Regions
India
62
South Africa
38
Global
28
Kenya
24
Brazil
24
Nigeria
22
Western and Central Europe
22
Latin America and the Carribbean
20
Philippines
18
Rwanda
18
Africa
17
Ethiopia
16
Tanzania
16
Malawi
16
Liberia
14
Ghana
12
Bangladesh
12
Uganda
11
South–East Asia Region
11
Sierra Leone
10
Nepal
10
Zambia
10
Cambodia
10
Indonesia
9
Asia
8
Eastern Europe
8
Haiti
7
Namibia
7
Myanmar / Burma
7
Germany
6
Syria
6
Mozambique
6
Paraguay
6
Congo, Democratic Republic of
5
Argentina
5
Chile
5
Eastern Europe and Central Asia
5
Senegal
4
Zimbabwe
4
South Sudan
4
Thailand
4
Ukraine
4
Lesotho
4
Middle East and North Africa
4
Guinea
3
Cameroon
3
Sudan
3
Peru
3
Colombia
3
West and Central Africa
3
Western Pacific Region
3
Venezuela
3
Russia
3
Burkina Faso
2
USA
2
Pakistan
2
Lebanon
2
China
2
Papua New Guinea
2
Eswatini/ Swaziland
2
Honduras
2
Bolivia
2
Yemen
2
East and Southern Africa
2
Southern Africa
2
Laos
2
Vietnam
2
Portugal
2
Malaysia
1
Benin
1
Central African Republic
1
North Macedonia
1
Ecuador
1
Botswana
1
El Salvador
1
Angola
1
Guatemala
1
Madagascar
1
Nicaragua
1
Fiji
1
Italy
1
Armenia
1
Tajikistan
1
Estonia
1
Moldova
1
Kazakhstan
1
Georgia
1
Denmark
1
United Kingdom
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
379
Clinical Guidelines
123
Women & Child Health
71
Public Health
68
Key Resources
40
Capacity Building
35
Pharmacy & Technologies
7
Toolboxes
COVID-19
110
Mental Health
108
Disability
66
HIV
65
Rapid Response
41
Caregiver
32
Zika
29
Ebola
26
NCDs
26
Planetary Health
25
TB
24
NTDs
22
AMR
21
Pharmacy
18
Global Health Education
17
Conflict
15
Refugee
15
Specific Hazards
8
Polio
4
Cholera
3
Natural Hazards
3
Health Financing Toolbox
2
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im...
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas...
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current COVID-19 pandemic. It also advises on the use of medical masks for children under certain conditions.
Lancet Glob Health 2020Published OnlineNovember 27, 2020 https://doi.org/10.1016/S2214-109X(20)30449-6
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical guidance needed to develop a communication plan that ...
ifo Schnelldienst, 2020, 73, Nr. 12, 46-57
Der Artikel zeigt, dass diskriminierende Strukturen und die besondere Schutzbedürftigkeit von geflüchteten Kindern durch das Auftreten von Covid-19 verstärkt werden. Geflüchtete Kinder verfügen über weniger digitale Ausstattung, teilweise werden si...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
What school closures under COVID-19 mean for children and young people in
crisis-affected contexts
This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of a...
What every clinician should know
Climate change, increasing population densities, and intensified globalisation in trade, travel and migration are among the most important factors shaping the 21st century. Each impacts upon population health and the risk of infectious disease, particularly those originating at the human-animal-envi...
WHO recommendations on maternal and newborn care for a positive postnatal experience. Presentation
recommended
This guideline aims to improve the quality of essential, routine postnatal care for women and newborns with the ultimate goal of improving maternal and newborn health and well-being. It recognizes a “positive postnatal experience” as a significant end point for all women giving birth and their n...
A global call to action to protect the mental health of health and care workers
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
The chapter Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time, is part of the publication series titled “Decade of Healthy Aging: situation and challenges”. This document aims to provide an outline of the current situation in Latin America and the C...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
